BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HAWM. Chest imaging in cystic fibrosis studies: What counts, and can be counted? J Cyst Fibros 2017;16:175-85. [PMID: 28040479 DOI: 10.1016/j.jcf.2016.12.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Beckmann N. Editorial for "Echo Time-Dependence of Observed Lung T1 in Patients With Cystic Fibrosis and Correlation With Clinical Metrics". J Magn Reson Imaging 2020;52:1655-6. [PMID: 32619307 DOI: 10.1002/jmri.27277] [Reference Citation Analysis]
2 Meerburg JJ, Hartmann IJC, Goldacker S, Baumann U, Uhlmann A, Andrinopoulou ER, Kemner V/D Corput MPC, Warnatz K, Tiddens HAWM. Analysis of Granulomatous Lymphocytic Interstitial Lung Disease Using Two Scoring Systems for Computed Tomography Scans-A Retrospective Cohort Study. Front Immunol 2020;11:589148. [PMID: 33193417 DOI: 10.3389/fimmu.2020.589148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lauwers E, Snoeckx A, Ides K, Van Hoorenbeeck K, Lanclus M, De Backer W, De Backer J, Verhulst S. Functional respiratory imaging in relation to classical outcome measures in cystic fibrosis: a cross-sectional study. BMC Pulm Med 2021;21:256. [PMID: 34348676 DOI: 10.1186/s12890-021-01622-3] [Reference Citation Analysis]
4 Hudock KM, Clancy JP. An update on new and emerging therapies for cystic fibrosis. Expert Opin Emerg Drugs 2017;22:331-46. [PMID: 29264936 DOI: 10.1080/14728214.2017.1418324] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
5 Newbegin K, Pilkington K, Shanthikumar S, Ranganathan S. Clinical utility of surveillance computed tomography scans in infants with cystic fibrosis. Pediatr Pulmonol 2018;53:1387-90. [DOI: 10.1002/ppul.24132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ciet P, Bertolo S, Ros M, Casciaro R, Cipolli M, Colagrande S, Costa S, Galici V, Gramegna A, Lanza C, Lucca F, Macconi L, Majo F, Paciaroni A, Parisi GF, Rizzo F, Salamone I, Santangelo T, Scudeller L, Saba L, Tomà P, Morana G. State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium. Eur Respir Rev 2022;31:210173. [PMID: 35321929 DOI: 10.1183/16000617.0173-2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dittrich AS, Kühbandner I, Gehrig S, Rickert-Zacharias V, Twigg M, Wege S, Taggart CC, Herth F, Schultz C, Mall MA. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis. Eur Respir J 2018;51:1701910. [PMID: 29545279 DOI: 10.1183/13993003.01910-2017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
8 Cohen-Cymberknoh M, Ben Meir E, Gartner S, Reiter J, Spangenberg A, Garriga L, Eisenstadt I, Israeli T, Tsabari R, Shoseyov D, Gileles-Hillel A, Breuer O, Simanovsky N, Kerem E. How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1. Pediatr Pulmonol 2021;56:2007-13. [PMID: 33704929 DOI: 10.1002/ppul.25371] [Reference Citation Analysis]
9 Sheahan KP, Glynn D, Joyce S, Maher MM, Boland F, O'Connor OJ. Best Practices: Imaging Strategies for Reduced-Dose Chest CT in the Management of Cystic Fibrosis-Related Lung Disease. AJR Am J Roentgenol 2021;217:304-13. [PMID: 34076456 DOI: 10.2214/AJR.19.22694] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 van Straten M, Brody AS, Ernst C, Guillerman RP, Tiddens HA, Nagle SK. Guidance for computed tomography (CT) imaging of the lungs for patients with cystic fibrosis (CF) in research studies. Journal of Cystic Fibrosis 2020;19:176-83. [DOI: 10.1016/j.jcf.2019.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
11 Wielpütz MO, Mall MA. MRI accelerating progress in functional assessment of cystic fibrosis lung disease. Journal of Cystic Fibrosis 2017;16:165-7. [DOI: 10.1016/j.jcf.2016.12.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE. Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement. Am J Respir Crit Care Med 2018;198:e116-36. [PMID: 30640517 DOI: 10.1164/rccm.201810-1895ST] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 9.7] [Reference Citation Analysis]
13 Wijker NE, Vidmar S, Grimwood K, Sly PD, Byrnes CA, Carlin JB, Cooper PJ, Robertson CF, Massie RJ, Kemner van de Corput MP, Cheney J, Tiddens HA, Wainwright CE. Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort. Eur Respir J 2020;55:1901694. [DOI: 10.1183/13993003.01694-2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Durmowicz AG. Cystic fibrosis radiographic biomarkers - Commentary. Journal of Cystic Fibrosis 2017;16:172. [DOI: 10.1016/j.jcf.2017.01.015] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Moutafidis D, Gavra M, Golfinopoulos S, Oikonomopoulou C, Kitra V, Woods JC, Kaditis AG. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation. Clin Imaging 2021;75:97-104. [PMID: 33515927 DOI: 10.1016/j.clinimag.2021.01.011] [Reference Citation Analysis]
16 Flume PA, Vandevanter DR. The challenges of maintaining momentum in CF drug development and approval - Commentary. Journal of Cystic Fibrosis 2017;16:170-1. [DOI: 10.1016/j.jcf.2017.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Tan JK, Banton G, Minutillo C, Hall GL, Wilson A, Murray C, Nathan EA, Verheggen M, Ramsay J, Samnakay N, Dickinson J. Long-term medical and psychosocial outcomes in congenital diaphragmatic hernia survivors. Arch Dis Child 2019;104:761-7. [DOI: 10.1136/archdischild-2018-316091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
18 Rosenow T. Quantification of CT bronchiectasis and its relationship to ventilation in cystic fibrosis. Thorax 2017;73:4-4. [DOI: 10.1136/thoraxjnl-2017-210917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
19 Abrami M, Ascenzioni F, Di Domenico EG, Maschio M, Ventura A, Confalonieri M, Di Gioia S, Conese M, Dapas B, Grassi G, Grassi M. A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients. Magn Reson Med 2018;79:2323-31. [PMID: 28833401 DOI: 10.1002/mrm.26876] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
20 Meerburg JJ, Veerman GDM, Aliberti S, Tiddens HAWM. Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review. Respir Med 2020;170:105954. [PMID: 32843159 DOI: 10.1016/j.rmed.2020.105954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Svedberg M, Imberg H, Gustafsson P, Brink M, Caisander H, Lindblad A. Chest X-rays are less sensitive than multiple breath washout examinations when it comes to detecting early cystic fibrosis lung disease. Acta Paediatr 2022;111:1253-60. [PMID: 35181935 DOI: 10.1111/apa.16302] [Reference Citation Analysis]
22 Loebinger MR, Polverino E, Blasi F, Elborn SJ, Chalmers JD, Tiddens HA, Goossens H, Tunney M, Zhou W, Angyalosi G, Hill AT, Haworth CS. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1). Pulmonary Pharmacology & Therapeutics 2019;58:101834. [DOI: 10.1016/j.pupt.2019.101834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Benlala I, Hocke F, Macey J, Bui S, Berger P, Laurent F, Dournes G. Quantification of MRI T2-weighted High Signal Volume in Cystic Fibrosis: A Pilot Study. Radiology 2020;294:186-96. [PMID: 31660805 DOI: 10.1148/radiol.2019190797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Saglani S. Lung function in primary ciliary dyskinesia: breaking the myth that this is a mild disease. Eur Respir J 2018;52:1801365. [PMID: 30139762 DOI: 10.1183/13993003.01365-2018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Goralski JL, Stewart NJ, Woods JC. Novel imaging techniques for cystic fibrosis lung disease. Pediatr Pulmonol 2021;56 Suppl 1:S40-54. [PMID: 32592531 DOI: 10.1002/ppul.24931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bischoff A, Weinheimer O, Eichinger M, Stahl M, Sommerburg O, Kauczor HU, Mall MA, Wielpütz MO. [Cystic fibrosis and computed tomography of the lungs]. Radiologe 2020;60:791-801. [PMID: 32621155 DOI: 10.1007/s00117-020-00713-2] [Reference Citation Analysis]
27 Zorzo C, Caballero P, Diab L, Pastor MT, Gómez-Punter RM, Girón RM. Predictive value of computed tomography scoring systems evolution in adults with cystic fibrosis. Eur Radiol 2020;30:3634-40. [PMID: 32128619 DOI: 10.1007/s00330-020-06759-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tiddens HAWM, Kuo W, van Straten M, Ciet P. Paediatric lung imaging: the times they are a-changin'. Eur Respir Rev 2018;27:170097. [PMID: 29491035 DOI: 10.1183/16000617.0097-2017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
29 Abrami M, Maschio M, Conese M, Confalonieri M, Di Gioia S, Gerin F, Dapas B, Tonon F, Farra R, Murano E, Zanella G, Salton F, Torelli L, Grassi G, Grassi M. Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients. Magn Reson Med 2020;84:427-36. [PMID: 31788856 DOI: 10.1002/mrm.28115] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Tiddens HAWM, Andrinopoulou ER, McIntosh J, Elborn JS, Kerem E, Bouma N, Bosch J, Kemner-van de Corput M. Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study. PLoS One 2020;15:e0240898. [PMID: 33141825 DOI: 10.1371/journal.pone.0240898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
31 Allenby MC, Woodruff MA. Biofabrication of personalised anatomical models and tools for the clinic. Journal of Cystic Fibrosis 2019;18:161-2. [DOI: 10.1016/j.jcf.2019.02.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Rossi Norrlund R, Meltzer C, Söderman C, Johnsson ÅA, Vikgren J, Molnar D, Gilljam M, Båth M. Evaluation of Two Chest Tomosynthesis Cystic Fibrosis Scoring Systems Using High-Resolution Computed Tomography Brody Scoring as Reference. Radiat Prot Dosimetry 2021:ncab057. [PMID: 33948650 DOI: 10.1093/rpd/ncab057] [Reference Citation Analysis]
33 Woods JC, Wild JM, Wielpütz MO, Clancy JP, Hatabu H, Kauczor HU, van Beek EJR, Altes TA. Current state of the art MRI for the longitudinal assessment of cystic fibrosis. J Magn Reson Imaging 2020;52:1306-20. [PMID: 31846139 DOI: 10.1002/jmri.27030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
34 Svedberg M, Gustafsson P, Tiddens H, Imberg H, Pivodic A, Lindblad A. Risk factors for progression of structural lung disease in school-age children with cystic fibrosis. Journal of Cystic Fibrosis 2020;19:910-6. [DOI: 10.1016/j.jcf.2019.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Chassagnon G, Zacharaki EI, Bommart S, Burgel PR, Chiron R, Dangeard S, Paragios N, Martin C, Revel MP. Quantification of Cystic Fibrosis Lung Disease with Radiomics-based CT Scores. Radiol Cardiothorac Imaging 2020;2:e200022. [PMID: 33778637 DOI: 10.1148/ryct.2020200022] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Short C, Semple T, Saunders C, Hughes D, Irving S, Gardener L, Rosenthal M, Robinson PD, Davies JC. A Short extension to multiple breath washout provides additional signal of distal airway disease in people with CF: A pilot study. J Cyst Fibros 2021:S1569-1993(21)01298-4. [PMID: 34275757 DOI: 10.1016/j.jcf.2021.06.013] [Reference Citation Analysis]